title: Interstitial Lung Disease in Children Younger Than 2 Years.
abstract: Childhood interstitial lung disease (chILD) represents a highly heterogeneous group of rare disorders associated with substantial morbidity and mortality. Although our understanding of chILD remains limited, important advances have recently been made, the most important being probably the appreciation that disorders that present in early life are distinct from those occurring in older children and adults, albeit with some overlap. chILD manifests with diffuse pulmonary infiltrates and nonspecific respiratory signs and symptoms, making exclusion of common conditions presenting in a similar fashion an essential preliminary step. Subsequently, a systematic approach to diagnosis includes a careful history and physical examination, computed tomography of the chest, and some or all of bronchoscopy with bronchoalveolar lavage, genetic testing, and if diagnostic uncertainty persists, lung biopsy. This review focuses on chILD presenting in infants younger than 2 years of age and discusses recent advances in the classification, diagnostic approach, and management of chILD in this age range. We describe novel genetic entities, along with initiatives that aim at collecting clinical data and biologic samples from carefully characterized patients in a prospective and standardized fashion. Early referral to expert centers and timely diagnosis may have important implications for patient management and prognosis, but effective therapies are often lacking. Following massive efforts, international collaborations among the key stakeholders are finally starting to be in place. These have allowed the setting up and conducting of the first randomized controlled trial of therapeutic interventions in patients with chILD.
authors.affiliation: Medical University Clinic, Canton Hospital Baselland, and University of Basel, Liestal, Switzerland; paolo.spagnolo@ksbl.ch.
authors.forename: Paolo
authors.initials: P
authors.lastname: Spagnolo
authors.affiliation: Royal Brompton Hospital and Harefield NHS Foundation Trust, London, United Kingdom; and National Heart and Lung Institute, Imperial College, London, United Kingdom.
authors.forename: Andrew
authors.initials: A
authors.lastname: Bush
mesh_terms: D018893:Bronchoalveolar Lavage; D005820:Genetic Testing; D006801:Humans; D007223:Infant; D017563:Lung Diseases, Interstitial / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D009154:Mutation; D012129:Respiratory Function Tests